CHARACTERIZATION OF HUMAN LEUKOTRIENE C4 SYNTHASE

人白三烯 C4 合成酶的表征

基本信息

  • 批准号:
    2459859
  • 负责人:
  • 金额:
    $ 8.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1995
  • 资助国家:
    美国
  • 起止时间:
    1995-08-01 至 2000-07-31
  • 项目状态:
    已结题

项目摘要

The proposed objective of this application relates to the study of the regulation of the cysteinyl leukotrienes by investigation their biosynthesis. This work has a significant impact on hyperresponsiveness of airways, particularly bronchial asthma, which acts over 3 million Americans. The cysteinyl leukotrienes (leukotrienes C4, D4, and E4) are lipid mediators implicated in the pathogenesis of this disease. Leukotriene C4 synthase catalyzes the first committed step in the formation of the cysteinyl leukotrienes by the conjugation of leukotriene (LT)A4 with reduced glutathione (GSH) to form leukotriene C4. The goal of this proposal is to characterize LTC4 synthase. The full length cDNA has been expressed in COS-7 cells and sf9 insect cells, yielding substantial amounts of biologically active enzyme. From these sources, the enzyme will be purified and its biochemical characteristics studied by kinetic analysis and compared to that of the native enzyme. Site-directed mutagenesis of the putative eicosanoid binding site and active site will elucidate the role of specific amino acids involved in the catalytic mechanism. Polyclonal antibodies have been raised to study the subcellular and cellular distribution as well as the distribution of LTC4 synthase in normal and asthmatic lungs. The final objective of this proposal will be to clone the human gene for LTC4 synthase, which will permit future studies of genomic regulation.
本申请提出的目的涉及对本发明的方法的研究。 调节半胱氨酰白三烯的研究, 生物合成这项工作对高反应性有重大影响, 气道,特别是支气管哮喘, 美国人半胱氨酰白三烯(白三烯C4、D4和E4)是 脂质介质参与这种疾病的发病机制。 白三烯C4合酶催化的第一个关键步骤, 通过白三烯的结合形成半胱氨酰白三烯 (LT)A4与还原型谷胱甘肽(GSH)形成白三烯C4。的目标 该建议是表征LTC 4合酶。全长cDNA具有 在COS-7细胞和sf 9昆虫细胞中表达, 生物活性酶的量。从这些来源,酶将 用动力学方法研究了其生化特性 分析并与天然酶进行比较。定点 假定的类二十烷酸结合位点和活性位点的诱变将 阐明参与催化的特定氨基酸的作用 机制多克隆抗体已被提出来研究亚细胞 和细胞分布以及LTC 4合酶在 正常和哮喘的肺。本提案的最终目标是 克隆人类LTC 4合酶基因,这将使未来 基因调控的研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN F PENROSE其他文献

JOHN F PENROSE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN F PENROSE', 18)}}的其他基金

PHENOTYPIC REGULATION EICOSANOID PATHWAYS OF HUMAN MAST CELLS IN VITRO
体外人体肥大细胞的表型调控二十烷酸途径
  • 批准号:
    6268422
  • 财政年份:
    1998
  • 资助金额:
    $ 8.69万
  • 项目类别:
CHARACTERIZATION OF HUMAN LEUKOTRIENE C4 SYNTHASE
人白三烯 C4 合成酶的表征
  • 批准号:
    2211335
  • 财政年份:
    1995
  • 资助金额:
    $ 8.69万
  • 项目类别:
CHARACTERIZATION OF HUMAN LEUKOTRIENE C4 SYNTHASE
人白三烯 C4 合成酶的表征
  • 批准号:
    2750243
  • 财政年份:
    1995
  • 资助金额:
    $ 8.69万
  • 项目类别:
CHARACTERIZATION OF HUMAN LEUKOTRIENE C4 SYNTHASE
人白三烯 C4 合成酶的表征
  • 批准号:
    6043649
  • 财政年份:
    1995
  • 资助金额:
    $ 8.69万
  • 项目类别:
HUMAN LEUKOTRIENE C4 SYNTHASE
人白三烯 C4 合成酶
  • 批准号:
    2211334
  • 财政年份:
    1995
  • 资助金额:
    $ 8.69万
  • 项目类别:

相似海外基金

Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
  • 批准号:
    22K09003
  • 财政年份:
    2022
  • 资助金额:
    $ 8.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
  • 批准号:
    21K07762
  • 财政年份:
    2021
  • 资助金额:
    $ 8.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
  • 批准号:
    20K16927
  • 财政年份:
    2020
  • 资助金额:
    $ 8.69万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
  • 批准号:
    20H00526
  • 财政年份:
    2020
  • 资助金额:
    $ 8.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
  • 批准号:
    20K21245
  • 财政年份:
    2020
  • 资助金额:
    $ 8.69万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
  • 批准号:
    G0900887/1
  • 财政年份:
    2011
  • 资助金额:
    $ 8.69万
  • 项目类别:
    Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
  • 批准号:
    05558090
  • 财政年份:
    1993
  • 资助金额:
    $ 8.69万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
  • 批准号:
    04453031
  • 财政年份:
    1992
  • 资助金额:
    $ 8.69万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了